Wednesday, June 24, 2026

Nikola Stock Bounces Back with 10% Surge After Previous Day’s 9% Drop

Nikola's stock surged over 10% after a sharp decline, driven by bargain hunters amid ongoing bankruptcy speculation.

NVIDIA’s Big Moment: Stock Market Awaits Earnings Surge and Future Outlook

Wall Street's leading beneficiary of generative artificial intelligence (AI), Nvidia, is counting down to its earnings announcement.

OpenAI’s Pioneer Program Aims to Reinvent AI Evaluation Standards

OpenAI launched the Pioneer Program to create industry-specific AI evaluation standards, addressing current benchmarks' flaws and biases.

Tag: immune diseases

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.